Cancer Biology & Therapeutics Program | Program Overview
CBT PROGRAM | PROGRAM OVERVIEW
Beginning in September 2016, the HMS Cancer Biology and Therapeutics Program (HMS-CBT) is a 12-month blended-learning program designed to provide participants with deep knowledge of the cancer biology that shapes modern preventive and therapeutic approaches. HMS-CBT is a joint initiative of the Harvard Medical School Office of Global Education and the Qatar Biomedical Research Institute (QBRI).
HMS-CBT will develop this expertise through an understanding of the molecular, cellular and host events that drive tumor formation, progression, and metastasis. How this knowledge is being used to develop our growing set of therapeutic and preventive approaches to fight cancer will be highlighted along with opportunities for participants to consider what new strategies are in development now. The program will cover important topics in screening, detection and diagnosis, as well as studies in clinical cancer genetics, pathology, and drug development. Leading faculty from HMS, HMS-affiliated hospitals, and other schools at Harvard, as well as other leading international institutions and organizations will be involved, both as faculty and as mentors.
- Attendance at three in-person workshops at the program’s beginning, mid-point and conclusion:
o September 27 – October 1, 2016: London, UK
o March 10 – 12, 2017: Harvard Medical School, Boston, Massachusetts
o September 28 - October 1, 2017: Harvard Medical School, Boston, Massachusetts
- 15 interactive live webinars with world experts in cancer
- 60 Pre-recorded lectures available 24/7
The program will be designed to be of use to clinicians and scientists specializing in cancer, as well as being a catalyst for participants in other disciplines to get a current survey of the major issues in cancer research. Participants will develop many opportunities to establish collaborations and exchanges with other experts in their region or across the world.
The HMS Office of Global Education has created a model that delivers the one-on-one interaction, superior quality and true innovation of the HMS educational experience to participants worldwide at the height of their careers. It provides participants with knowledge, skills training and access to world leaders in cancer care and research. Even more, it creates a global network that has proven to be a key component of individual success and regional advancement. Participants receive experience-based training on how to work effectively with collaborators across borders and time zones, leveraging technology to create global collaborative research efforts.